Preliminary Programme

1st World NET Forum

Hybrid Event, 8 - 9 March 2022, in Barcelona, Spain

World NET Forum in 2022

ENETS has worked together with our partner NET societies around the world (incl. NANETS, APNETS, COMMNETS, CSNET, CNETS, JNETS, Argentum, NET Initiatives in South America, and INCA) on a first-class scientific programme aimed at bringing the leading scientists in the field of neuroendocrine neoplasms together to connect and inspire clinicians and scientists at the cutting edge of NET research.

Please look at the preliminary programme below.

Become an ENETS member today and benefit from the best conference fee.

Preliminary Programme

8 - 9 March 2022 - Hybrid Event

Tuesday, 08 March 2022

Welcome

Time: Tuesday 11:00 - 11:10
Marianne Pavel, GER /

Session 1: Models in NET research

Time: Tuesday 11:10 - 12:20
Chairs: Jie Chen, CHN / Anne Couvelard, FRA / Robert T. Jensen, USA /
11:10 - 11:40 Keynote address: An organoid biobank of neuroendocrine neoplasms enables genotype-phenotype mapping
Kenta Kawasaki, JPN /
11:40 - 12:00 Talk 1: State-of-the-art NET tumor models: Present & future
Dawn Quelle, USA /
12:00 - 12:20 Discussion

Coffee break

Time: Tuesday 12:20 - 12:50

Session 2: NET tumor biology advances

Time: Tuesday 12:50 - 14:45
Chairs: Emily Bergsland, USA / Aurel Perren, SUI /
12:50 - 13:20 Keynote address: Understanding tumor biology of NEN by integrated genomic analysis
Aldo Scarpa, ITA /
13:20 - 13:30 Discussion
13:30 - 13:45 Talk 1: Epigenetic control of human intestinal neuroendocrine cell differentiation
Ramesh Shivdasani, USA /
13:45 - 13:55 Discussion
13:55 - 14:10 Talk 2: Immune and stromal heterogeneity associated with cellular origin and cancer evolution in GEP-NET
Anguraj Sadanandam, GBR /
14:10 - 14:20 Discussion
14:20 - 14:35 Talk 3: Mechanisms of RB loss in neuroendocrine carcinoma
Nancy Joseph, USA /
14:35 - 14:45 Discussion

Summary of the day

Time: Tuesday 14:45 - 15:00
Justo P. Castaño, ESP /

Wednesday, 09 March 2022

Welcome

Time: Wednesday 11:00 - 11:10

Session 3: Therapeutic advances in NET

Time: Wednesday 11:10 - 12:40
Chairs: Bertram Wiedenmann, GER / Hong Zhao, CHN /
11:10 - 11:40 Keynote address: Deciphering NET tumor invasiveness to potentiate real therapy candidates
Douglas Hanahan, /
11:40 - 11:50 Discussion
11:50 - 12:05 Talk 1: From genomics to functional genomics: The discovery and targeting of ATRX and MEN1 mutations in PanNETs
Yuchen Jiao, CHN /
12:05 - 12:15 Discussion
12:15 - 12:30 Talk 2: Mechanisms of resistance to PRRT and overcoming these
Rod Hicks, AUS /
12:30 - 12:40 Discussion

Coffee break

Time: Wednesday 12:40 - 13:10

Session 4: Novel areas in NET diagnostic and therapy

Time: Wednesday 13:10 - 14:40
Chairs: B.A. Krishna, / Kjell Öberg, SWE / Hironobu Sasano, JPN /
13:10 - 13:40 Keynote address: Precision oncological approach in neuroendocrine tumors (lessons from NET and other cancers)
Andrea Califano, USA /
13:40 - 13:50 Discussion
13:50 - 14:05 Talk 1: New radionuclides for improved diagnosis and therapy in NET
Cristina Müller, SUI /
14:05 - 14:15 Discussion
14:15 - 14:30 Talk 2: CAR-T cell technology
Xianxin Hua, USA /
14:30 - 14:40 Discussion

Summary of the day

Time: Wednesday 14:40 - 14:55
Marianne Pavel, GER /

Closing comments

Time: Wednesday 14:55 - 15:05
Marianne Pavel, GER /